Research Article
Bacteraemia in Intensive Care Unit: Clinical, Bacteriological, and Prognostic Prospective Study
Table 3
Antimicrobial resistance rate of Gram negative bloodstream isolates.
| | Drug | Enterobacteriaceae
| Klebsiella Pneumoniae | Nonfermentative GNB | Acinetobacter baumannii | Pseudomonas aeruginosa |
| | Amoxi-Clavulanate | 64,2% | 60% | NT | NT | NT | | Pip-Tazobactam | 23,8% | 20% | 82,3% | 100% | 20% | | Cefalotin | 64,2% | 60% | NT | NT | NT | | Ceftazidime | 57,1% | 60% | 70% | 100% | 20% | | Ceftriaxone | 50% | 60% | NT | NT | NT | | Imipenem | 0% | 0% | 78,9% | 100% | 20% | | Ertapenem | 12,5% | 20% | NT | NT | NT | | Cefoxitime | 8,3% | 10% | NT | NT | NT | | Gentamicin | 37,5% | 50% | 63,1% | 83,3% | 20% | | Tobramycin | 32% | 50% | 50% | 53,8% | 20% | | Amikacin | 4% | 0% | 47,3% | 50% | 20% | | Netilmicin | 36% | 50% | 45% | 46,1% | 40% | | Ciprofloxacin | 40% | 70% | 70% | 100% | 20% | | Cotrimoxazole | 64% | 80% | 85% | 92,3% | 100% | | Fosfomycin | 0% | 0% | NT | NT | NT | | Colistin | 0% | 0% | 0% | 0% | 0% | | Ticarcillin | NT | NT | 88,2% | 100% | 33,3% | | Piperacillin | NT | NT | 72,2% | 100% | 20% | | Rifampicin | NT | NT | 42,8% | 46,1% | 0% |
|
|
